ISSCA doctors to serve as keynote speakers at international conference and will host an additional stem cells course in Barcelona.

MIAMI LAKES, Florida— The International Society for Stem Cell Application (ISSCA), a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, has accepted an invitation to speak at the XXVIIas Jornadas Mediterraneas de Confrontaciones Terapeuticas en Medicina y Cirugia Cosmetica in Barcelona. The conference will be held on May 23-25, 2019 at the Hotel Barceló Sants, with experts from ISSCA leading the keynote session on May 25th. Following the conference on May 26th,, ISCCA doctors will also be hosting a one-day stem cells course for practitioners of regenerative medicine.

Dra. Maritza Novas of the United States and Dr. Leopoldo Parada of Chile will be speaking on behalf of ISSCA about new therapies based on allogenic compounds such as amniotic liquid, Wharton’s jelly, cord blood, and exosomes and how they present exciting new treatment opportunities for those practicing regenerative medicine.

Drs. Novas and Parada will shed light on new advances in allogenic compound research and share details with regenerative medicine practitioners on how allogenic compounds are safe treatment options for their patients, as they must pass through rigorous quality control in labs before being shipped to medical offices. Additionally, independent tests show that allogenic compounds have better cellular counts than other biological matter. Doctors currently using allogenic compounds have also reported faster treatment times associated with allogenic protocols, citing a 15-minute turnaround time versus 2 hours required to obtain stem cells from their patients.

After completing their keynote talk at Jornadas Mediterraneas, Drs. Nova and Parada will be leading a one-day stem cells seminar to discuss in further detail allogenic compound clinical applications and the latest clinical trials. The seminar will wrap up with a live patient demonstration.

ISSCA has attended Jornadas Mediterraneas for the last six years. It is a premier conference in the medical community attracting more than 500 doctors from across the globe each year.

To learn more about ISSCA and all of their upcoming and past events, visit

ISSCA’s training programs assist physicians and researchers in developing better protocols for stem cell treatments.

MIAMI LAKES, Florida— The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is continuing to expand its global training efforts by sponsoring three upcoming training sessions over the next month. The group has a busy schedule, with trainings taking place in Amsterdam, Abu Dhabi, Atlanta, Bogota, Miami and Mexico City.

ISSCA instructors will be hosting two onsite trainings, one in Amsterdam, Netherlands on February 22-23 and another in Abu Dhabi, United Arab Emirates on March 2-3. The training is designed to assist physicians interested in introducing regenerative medicine into their practices adhere to industry practices. Physicians will learn about industry developments and the latest advances in cellular-based treatment protocols.

Utilizing ISSCA’s over 10 years of experience in regenerative medicine, the onsite trainings seek to bring the latest advances in the field to physicians across the world, removing barriers to access. In addition to training physicians, the group uses hands-on-training methods to instruct other medical staff in cellular treatment protocols so they can effectively assist their tending physicians. Trainings are highly personalized and offer physicians the ability to learn only the regenerative medicine treatments they are most interested in.

In early March, ISSCA instructors will also be traveling to Atlanta, Georgia to train physicians on allogenic compound stem cells derived from cord blood. This two-day training will take place in on March 29-30. Physicians with an interest in new regenerative medicine breakthroughs that have produced safer and shorter recovery times and those that have led to higher cellular counts in the degenerative disease treatment process will find this training of interest.

Instructors will lead physicians through a deep dive into the latest stem cell advances pertaining to cord blood research. Attendees will learn about processes for how to extract stem cells from a healthy donor and protocols on how to process stem cells in the lab while adhering to the highest quality control standards.

Instructors will additionally share the science behind allogenic compounds derived from cord blood and which current protocols use cord blood derived stem cells to promote patient healing.

ISSCA trainers will be rounding out their upcoming training schedule with visits to Bogota, Colombia on March 15-16, Miami, Florida on March 22-23 and Mexico City, Mexico on March 29-30. These three trainings will offer Stem Cell Training Certification for physicians seeking to expand their knowledge on the newest stem cells protocols for those wanting to integrate regenerative medicine into their practices. The protocols covered in the trainings can be implemented in medical offices with mini lab equipment. The instructors will engage physicians in hands-on instruction where doctors can practice on live patients.

Trainings in Bogota and Mexico City will be conducted in Spanish, and interested participants can find more information at, while interested Miami participants can learn more at

To learn more about ISSCA, visit

ISSCA to host upcoming regenerative medicine conference in Miami that provides training on allogeneic cellular-based products

MIAMI LAKES, Florida—The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, is set to host a conference in Miami on October 25-26, 2019.

The conference will be held at the Biltmore Hotel and will offer more than 250 attendees the opportunity to learn more about allogenic cellular-based products and how they play a critical role in the future of regenerative medicine.


Physicians looking for new alternatives to improve the quality of life of their patients through emerging regenerative medicine protocols and advances are encouraged to attend the Miami conference. In this two-day event, attendees will learn why allogeneic cellular-based products have become today’s most popular regenerative medicine therapeutic option.

Well-respected scientists and researchers in the field of regenerative medicine from across the globe world will share with the audience the basic concepts needed to determine which allogenic cellular-based products are safe to use and what type of clinical indications can be targeted effectively.

“We are pleased to bring this informative and exciting conference to Miami,” said Benito Novas Global Stem Cells Group Founder and CEO. “Our goal is to give doctors the knowledge they need to begin implementing cellular-based treatments in their own practices. These types of treatments have been proven effective in a host of clinical scenarios, including speeding up the patient’s rate of recovery and pain management.”

To learn more about ISSCA, visit

ISSCA’s training assists hospital in developing better protocols for gynecological treatments.

MIAMI LAKES, Florida—The International Society for Stem Cell Application, a multi-disciplinary community of scientists and physicians collaborating to treat diseases and lessen human suffering through science, technology, and regenerative medicine, traveled to Guadalajara, Mexico in early February to collaborate with area physicians on how to utilize advancements in stem cell research and technology to find new solutions to health issues and concerns.

During ISSCA’s visit to Hospital Angeles del Carmen, physicians with the group partnered with Dr. Norma Patricia Ramos, director of the hospital’s gynecological department. During the two-day visit, ISSCA’s researchers and physicians provided valuable training and guidance on how stem cells can be used to develop better protocols for treating vaginal stenosis.

Vaginal stenosis is a condition that causes narrowing and/or loss of flexibility of the vagina and is a side effect of radiotherapy and/or genital surgery. It is often also accompanied by dryness and loss of resiliency of scar tissue.

The group reviewed new and effective treatment protocols available through stem cell therapies, including combining traditional CO2 laser treatments with stem cells harvested from adipose tissue.

The group also worked with Dr. Ramos and her team on new stem cell protocols to help women who have tried in vitro fertilization to get pregnant but have not experienced success due to a lack of ovarian reserves. The ISSCA group shared new research on the viability of utilizing stem cells from adipose tissue or bone marrow and reintegrating it into the ovaries using a laparoscopy with the goal of increasing ovarian reserves and increasing chances of pregnancy. Poor ovarian reserve (POR) is critical limiting factor for the success of any treatment modality for infertility, and new stem cell treatments provide a promising treatment protocol in increasing the quantity and quality of oocytes in women of reproductive age.

ISSCA is committed to partnering with physicians and researchers worldwide who have a vested interest in finding new solutions to improve treatments for any conditions. The group has an upcoming trip to Buenos Aires to partner with orthopedic doctors to discuss opportunities for stem cell therapies to improve treatment protocols in the field of orthopedics.

To learn more about ISSCA, visit

About ISSCA:

The International Society for Stem Cells Applications (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology, and the practice of regenerative medicine. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

ISSCA bridges the gaps between scientists and practitioners in Regenerative Medicine.  Their code of ethics emphasizes principles of morals and ethical conducts.

At ISSCA, their vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification. ISSCA serves its members through advancements made to the specialty of regenerative medicine. They aim to encourage more physicians to practice regenerative

medicine and make it available to benefit patients both nationally and globally.

For more information, please visit or send an email to